D-Pharm Business Development Unit US Company Profile

20:36 EDT 17th March 2018 | BioPortfolio

Established in April 1993 by Dr. Alex Kozak, D-Pharm is a specialty pharmaceutical company that designs and develops innovative drugs for the treatment of the most devastating brain disorders. The Company has developed two
unique platform technologies that generate lipid–like medicines which utilise lipid specific mechanisms and lipid-related pathways in living cells. The Company’s drug candidates are New Chemical Entities protected by patents and patent applications in a wide range of countries


C/O Care Capital 47 Hulfish Street, Suite 310
New Jersey
United States of America


Phone: 1- 609-683-8300
Fax: 1-609-683-5787

News Articles [1002 Associated News Articles listed on BioPortfolio]

Covance establishes new global unit for biologic drug development

LabCorp's Covance Drug Development business has established a global immunology and immunotoxicology (I&I) unit to focus on the development of biologic drugs.

Pall Launches Biotech Business Unit

The new unit has been named to reflect an important strategic direction for the company

Pfizer may sell consumer unit

The drug developer said Tuesday that the business, including the Centrum brand of vitamins, Robitussin and ChapStick, is distinct enough from its core biopharmaceutical business that there may be more...

Israel's Super-Pharm in talks to buy Teva Pharm plant -media

Israel's largest pharmacy chain Super-Pharm Ltd is in talks to acquire Teva Pharmaceutical Industries' plant in the coastal city of Ashdod, Israeli media said on Sunday. The Calcalist website ...

Pharma R&D unit at Bayer to come under single leadership, with new head

Following the formation of a dedicated strategic business unit oncology earlier this year within its…

CIT Names Mike Jones To Lead Business Capital Unit And Jeff Lytle To Lead Rail Unit

Steve Solk, who previously was president of  both the Business Capital and Consumer Banking units, will now focus on the Consumer Banking business as Read more...

Nisanov Brothers buys eleven New-Pharm branches

The sale paves the way for completion of the larger deal whereby Shufersal is buying New-Pharm from Hamashbir. 

Lee's Pharm to Start China Trials of In-licensed PD-L1 Candidate

A subsidiary of Lee's Pharm received permission to begin China clinical trials of ZKAB001, a PD-L1 immuno-oncology monoclonal antibody. Lee's Pharm, a Hong Kong company, in-licensed greater China righ...

PubMed Articles [1472 Associated PubMed Articles listed on BioPortfolio]

Inpatient Dialysis Unit Project Development: Redesigning Acute Hemodialysis Care.

Executive leaders of an acute care hospital performed a market and financial analysis, and created a business plan to establish an inpatient hemodialysis unit operated by the hospital to provide safe,...

Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial.

We examined whether electroconvulsive therapy (ECT) plus medications ("STABLE + PHARM" group) had superior HRQOL compared with medications alone ("PHARM" group) as continuation strategy after succes...

Business Education for Plastic Surgeons: A Systematic Review, Development, and Implementation of a Business Principles Curriculum in a Residency Program.

Reply: Business Education for Plastic Surgeons: A Systematic Review, Development, and Implementation of a Business Principles Curriculum in a Residency Program.

Care coordination in a business-to-business and a business-to-consumer model for telemonitoring patients with chronic diseases.

For telemonitoring to support care coordination, a sound business model is conditional. The aim of this study is to explore the systemic and economic differences in care coordination via business-to-b...

Clinical Trials [2905 Associated Clinical Trials listed on BioPortfolio]

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

This is a Phase 1 single site study to evaluate the safety and efficacy of a combination therapy that includes the administration of vismodegib and photodynamic therapy (PDT) using aminole...

Bioequivalence Study of Rivaroxaban From Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Industries, Egypt) and Xarelto® 10 mg Tablets (Janssen Pharm., Licensed From: Bayer Healthcare, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Rivaroxaban from Repatoxaban 10 mg Tablets (Horus for Pharmaceutical Indust...

Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will con...

Tobacco Control Among Business Process Outsourcing (BPO) Employees

The Business Process Outsourcing BPO industry has been rapidly expanding in India over the last 10 years. There is a concern regarding issues of health and safety that are unique to this n...

Evaluation of the Impact of the Presence of a Pharmacy Technician on the Quality and Cost of Drug Therapy

The main objective of this study is to evaluate the impact of the presence of a pharmacy technician in a care unit (Hepato-Gastroenterology Department) on detected medication errors. ...

Companies [2587 Associated Companies listed on BioPortfolio]

D-Pharm Business Development Unit US

Established in April 1993 by Dr. Alex Kozak, D-Pharm is a specialty pharmaceutical company that designs and develops innovative drugs for the treatment of the most devastating brain disorders. The Com...

NP Pharm

Founded in January 1992, NP Pharm is a private company, part of the Pharmaceutical group ETHYPHARM, which is one of the world leading companies for Drug Delivery Systems (DDS). Based, on a large exper...

Pharm-Olam International Ltd.

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology...

D-Pharm Ltd

D-Pharm ( is a technology-driven biopharmaceutical company focused on the discovery and development of innovative proprietary drugs for the treatment of central nervous syste...

Beijing Med-Pharm Corp

Beijing Med-Pharm offers an end-to-end solution to U.S and western pharmaceutical companies wishing to sell their products in China. We offer sales and marketing services throughout China and can help...

More Information about "D-Pharm Business Development Unit US" on BioPortfolio

We have published hundreds of D-Pharm Business Development Unit US news stories on BioPortfolio along with dozens of D-Pharm Business Development Unit US Clinical Trials and PubMed Articles about D-Pharm Business Development Unit US for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of D-Pharm Business Development Unit US Companies in our database. You can also find out about relevant D-Pharm Business Development Unit US Drugs and Medications on this site too.

Quick Search


Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Corporate Database Quicklinks

Searches Linking to this Company Record